Matches in Wikidata for { <http://www.wikidata.org/entity/Q74377095> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q74377095 description "artículu científicu espublizáu en marzu de 1998" @default.
- Q74377095 description "scientific article published on 01 March 1998" @default.
- Q74377095 description "wetenschappelijk artikel" @default.
- Q74377095 description "наукова стаття, опублікована в березні 1998" @default.
- Q74377095 name "Heterogeneous expression of E-cadherin and p53 in prostate cancer: clinical implications. BIOMED-II Markers for Prostate Cancer Study Group" @default.
- Q74377095 name "Heterogeneous expression of E-cadherin and p53 in prostate cancer: clinical implications. BIOMED-II Markers for Prostate Cancer Study Group" @default.
- Q74377095 type Item @default.
- Q74377095 label "Heterogeneous expression of E-cadherin and p53 in prostate cancer: clinical implications. BIOMED-II Markers for Prostate Cancer Study Group" @default.
- Q74377095 label "Heterogeneous expression of E-cadherin and p53 in prostate cancer: clinical implications. BIOMED-II Markers for Prostate Cancer Study Group" @default.
- Q74377095 prefLabel "Heterogeneous expression of E-cadherin and p53 in prostate cancer: clinical implications. BIOMED-II Markers for Prostate Cancer Study Group" @default.
- Q74377095 prefLabel "Heterogeneous expression of E-cadherin and p53 in prostate cancer: clinical implications. BIOMED-II Markers for Prostate Cancer Study Group" @default.
- Q74377095 P1433 Q74377095-D2755D11-30AC-44A3-88C2-036DED8AFDEB @default.
- Q74377095 P1476 Q74377095-40E75C12-7B99-47EA-AF1B-8DC9D4B8BB7A @default.
- Q74377095 P2093 Q74377095-105C4830-1B86-4F5E-95DB-365DBAA2CFFD @default.
- Q74377095 P2093 Q74377095-1666285F-7F93-4B52-8C71-E800A1E39552 @default.
- Q74377095 P2093 Q74377095-2D13474F-CC4E-4F7B-B21A-3F3A1F31A986 @default.
- Q74377095 P2093 Q74377095-43E6F55D-1A7D-426E-98EA-BE41729048E5 @default.
- Q74377095 P2093 Q74377095-483DACFA-252D-4664-B5E4-22D8B09D0475 @default.
- Q74377095 P2093 Q74377095-5A1DA4E9-5BDB-4B9C-A6F1-F540896F96D2 @default.
- Q74377095 P2093 Q74377095-6844F431-4E82-40F1-A4F4-B1D7A5C2AE13 @default.
- Q74377095 P304 Q74377095-C566275A-4C48-4331-B2E3-ED19A407D126 @default.
- Q74377095 P31 Q74377095-23D95B6B-C97D-41EE-880E-5D45CD47530F @default.
- Q74377095 P433 Q74377095-4A58B469-09FC-4AAF-A9DE-A51CC1398F6E @default.
- Q74377095 P478 Q74377095-89A1F075-227D-4D09-BEBB-B9906EB7F655 @default.
- Q74377095 P577 Q74377095-2180F75C-EEAD-443D-AED1-3FB44FE9A58A @default.
- Q74377095 P698 Q74377095-675B9B36-13E1-4953-998E-2058BF03EC8A @default.
- Q74377095 P921 Q74377095-C5A7FF87-8760-4852-BFF0-7E280ED1461A @default.
- Q74377095 P698 9521475 @default.
- Q74377095 P1433 Q15724578 @default.
- Q74377095 P1476 "Heterogeneous expression of E-cadherin and p53 in prostate cancer: clinical implications. BIOMED-II Markers for Prostate Cancer Study Group" @default.
- Q74377095 P2093 "Aalders T" @default.
- Q74377095 P2093 "Debruyne F" @default.
- Q74377095 P2093 "Miller G" @default.
- Q74377095 P2093 "Ruijter E" @default.
- Q74377095 P2093 "Ruiter D" @default.
- Q74377095 P2093 "Schalken J" @default.
- Q74377095 P2093 "van de Kaa C" @default.
- Q74377095 P304 "276-281" @default.
- Q74377095 P31 Q13442814 @default.
- Q74377095 P433 "3" @default.
- Q74377095 P478 "11" @default.
- Q74377095 P577 "1998-03-01T00:00:00Z" @default.
- Q74377095 P698 "9521475" @default.
- Q74377095 P921 Q181257 @default.